Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer

Table 1 The relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer

Parameter	n	E-cadherin (%)		α-catenin (%)		β-catenin (%)
		Normal	Abnormal	Normal	Abnormal	Normal	Abnormal
Mass size (cm)
< 3	9	5 (55.6)	4 (44.4)	4 (44.4)	5 (55.6)	3 (33.3)	6 (66.7)
3-5	15	7 (46.7)	8 (53.3)	5 (33.3)	10 (66.7)	4 (26.7)	11 (73.3)
> 5	23	10 (43.5)	13 (56.5)	9 (39.1)	14 (60.9)	8 (34.8)	15 (65.2)
Histologic grade
I	10	9 (90.0)	1 (10.0)	7 (70.0)	3 (30.0)	5 (50.0)	5 (50.0)
II	16	8 (50.0)	8 (50.0)	7 (43.8)	9 (56.2)	6 (37.5)	10 (62.5)
III	21	5 (23.8)	16 (76.2)	4 (19.0)	17 (81.0)	4 (19.0)	17 (81.0)
Invasive state
Invasion	30	12 (40.0)	18 (60.0)	9 (30.0)	21 (70.0)	8 (26.7)	22 (73.3)
No invasion	17	10 (58.8)	7 (41.2)	9 (52.9)	8 (47.1)	7 (41.2)	10 (58.8)
Metastases	19	6 (31.6)	13 (68.4)a	5 (26.3)	14 (73.7)a	3 (15.8)	16 (84.2)a
Lymph node
Liver	12	2 (16.7)	10 (83.3)a	0	12 (100.0)b	0	12 (100.0)b
No	22	14 (63.6)	8 (36.4)	13 (59.1)	9 (40.9)	12 (54.5)	10 (45.5)
Survival time (month)
> 12	9	6 (66.7)	3 (33.3)	5 (55.6)	4 (44.4)	4 (44.4)	5 (55.6)
≤ 12	38	16 (42.1)	22 (57.9)	13 (34.2)	25 (65.8)	11 (28.9)	27 (71.1)

^aP < 0.05, versus no metastasis;

^bP < 0.01, versus no metastasis.